Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
64.5M
-
Shares change
-
+474K
-
Total reported value, excl. options
-
$887M
-
Value change
-
+$4.03M
-
Put/Call ratio
-
0
-
Number of buys
-
79
-
Number of sells
-
-56
-
Price
-
$13.76
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q2 2022
162 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q2 2022.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.5M shares
of 107M outstanding shares and own 60.15% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (15.8M shares), BlackRock Inc. (4.01M shares), WELLINGTON MANAGEMENT GROUP LLP (3.41M shares), VANGUARD GROUP INC (3.36M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (3.35M shares), STATE STREET CORP (2.54M shares), MAVERICK CAPITAL LTD (2.53M shares), RA CAPITAL MANAGEMENT, L.P. (2.11M shares), Assenagon Asset Management S.A. (1.69M shares), and CITADEL ADVISORS LLC (1.51M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.